Related Experiment Video
Updated: Mar 15, 2026
Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models
Renu A Kowluru1, Manish Mishra1, Anjaneyulu Kowluru2
1Ophthalmology, Wayne State University, Detroit, MI, United States.
Aim:
In the pathogenesis of diabetic retinopathy, reactive oxygen species (ROS) are elevated in the retina and the mitochondria are damaged, resulting in accelerated apoptosis. Dyslipidemia is also considered as one of the major factors in its development, and our aim is to investigate the compounding effect of hyperlipidemia in retinopathy.
Methods:
Retinal ROS, mitochondrial damage and vascular pathology were investigated in Zucker diabetic fatty rats (ZDF, type 2 diabetes model), during the age that spans from hyperlipidemia/pre-hyperglycemia (6weeks), to severe hyperglycemia/moderate hyperlipidemia (~12weeks), and ultimately to severe hyperglycemia/hyperlipidemia (20-40weeks). For comparison, retina from streptozotocin-induced Wistar rats (type 1 diabetic for 10-40weeks) was analyzed.
Results:
Compared to age-matched lean rats, despite increased retinal cytosolic ROS in 6-week-old ZDF rats, mitochondrial dysfunction and DNA damage were not detected, and in 12-week-old ZDF rats, retinal mitochondria were dysfunctional, but mtDNA damage and vascular pathology (cell apoptosis and degenerative capillaries) were not detectable. Retina from 20-week-old ZDF rats (hyperglycemic for 14weeks or less) had significant mitochondrial dysfunction, mtDNA damage and vascular pathology, and similar abnormalities were observed in 40-week-old ZDF rats. Although retinal mitochondrial dysfunction was observed in Wistar rats diabetic for 20weeks, mtDNA damage and vascular pathology were not detectable till the duration of diabetes was further extended.
Conclusions:
Hyperlipidemia, in a hyperglycemic milieu, potentiates mitochondrial damage and augments the development of retinopathy. Control of dyslipidemia in pre-diabetic patients may prevent/delay the development and the progression of this devastating disease.
Insights
Hyperlipidemia exacerbates diabetic retinopathy by worsening mitochondrial damage and vascular pathology in the retina. Managing dyslipidemia in pre-diabetic individuals may prevent or delay this severe eye disease.
Area of Science:
- Ophthalmology
- Endocrinology
- Mitochondrial Biology
Background:
- Diabetic retinopathy involves retinal oxidative stress, mitochondrial damage, and apoptosis.
- Dyslipidemia is a significant contributing factor to diabetic retinopathy development.
- The combined impact of hyperglycemia and hyperlipidemia on retinopathy requires further investigation.
Purpose of the Study:
- To investigate the compounding effect of hyperlipidemia on retinopathy development in a type 2 diabetes model.
- To analyze retinal reactive oxygen species (ROS), mitochondrial damage, and vascular pathology progression.
Main Methods:
- Zucker diabetic fatty (ZDF) rats (type 2 diabetes) were studied from 6 to 40 weeks of age, spanning pre-hyperglycemia to severe diabetes.
- Retinal analysis included ROS levels, mitochondrial dysfunction, mtDNA damage, and vascular pathology.
- Streptozotocin-induced Wistar rats (type 1 diabetes) were used for comparison.
Main Results:
- In ZDF rats, mitochondrial dysfunction and vascular pathology correlated with the duration of hyperglycemia and hyperlipidemia.
- Significant mitochondrial dysfunction, mtDNA damage, and vascular pathology were evident by 20 weeks in ZDF rats.
- Wistar rats showed mitochondrial dysfunction, but mtDNA damage and vascular pathology appeared later, requiring longer diabetes duration.
Conclusions:
- Hyperlipidemia potentiates mitochondrial damage and accelerates retinopathy in a hyperglycemic environment.
- Controlling dyslipidemia in pre-diabetic patients could prevent or delay diabetic retinopathy.
- Early intervention targeting dyslipidemia may be crucial for managing diabetic eye disease.
